Tamoxifen Shockingly Found to Cause Aggressive Breast Cancer

Long-term Tamoxifen use, as widely promoted bycancer prevention.  At that time it was clear that
oncologists for women following breast cancer, turnsTamoxifen increased leptin levels, thus provoking an
out to increase the risk of highly aggressive hormoneincrease in inflammation that causes increased cancer
receptor-negative breast cancer by 440%.  Thisrisk.  Due to this, women on Tamoxifen are likely to
means that while Tamoxifen reduces the risk for lessgain weight, thus inducing insulin resistance (and IGF1
invasive estrogen positive cancer by 60%, it is at theconfusion in breast tissue), which again leads to
same time putting many women in extreme peril.increased risk for another breast cancer.  Tamoxifen
The lead researcher, Christopher Li, M.D., Ph.D., atalso causes fatty liver congestion, increased risk for
Fred Hutchinson Cancer Research Center seemedendometrial cancer, vaginal bleeding and discharge,
more apologetic than anything in quotes from hismajor circulatory adverse events, and hot flashes.
press release, almost embarrassed to publish theOf course, the FDA doesn’t do anything about
results for fear of professional backlash.  Thisthis because they are inept at making drug
position reflects the extreme pressure researcherscompanies do the follow up safety testing required
find themselves in when they publish studies thatby law.  The FDA simply sits around until a
would cause almost any woman to not takecatastrophe blows up in its face, and then they
Tamoxifen.move like a tortoise trying to cross the road –
Dr. Li’s fear is testament to the sickness thathoping to limit liability for the drug company involved.
pervades the medical community’s use ofIt is hard to know if the medical profession will ever
drugs.  His study is unlikely to change any prescribingwake up to the damage they are causing in the
practices in America, as short-sighted doctors willname of “help.”  If you are a woman taking
decide in their own minds that the benefits ofTamoxifen and you have gained weight or you
Tamoxifen outweigh the risks – even when thecan’t lose weight, you need to find something
data says it doesn’t.  In essence, his data is notelse to do because the risks likely outweigh the
welcome.benefits.
In 2002, in my book Mastering Leptin, I pointed outTo prevent a second cancer you must get insulin,
the ridiculousness of using Tamoxifen for breastleptin, and IGF1 signals working in harmony.